Sinopharm
1099.HK
#1947
Rank
NZ$14.04 B
Marketcap
$4.50
Share price
-3.52%
Change (1 day)
8.27%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: NZ$14.04 Billion

As of November 2024 Sinopharm has a market cap of NZ$14.04 Billion. This makes Sinopharm the world's 1947th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$14.04 B8.66%
2023NZ$12.92 B3.27%
2022NZ$12.51 B25.92%
2021NZ$9.93 B-0.61%
2020NZ$9.99 B-37.97%
2019NZ$16.11 B-13.4%
2018NZ$18.61 B10.48%
2017NZ$16.84 B2.37%
2016NZ$16.45 B1.45%
2015NZ$16.22 B29.8%
2014NZ$12.49 B39.37%
2013NZ$8.96 B-1.86%
2012NZ$9.13 B23.63%
2011NZ$7.39 B-27.69%
2010NZ$10.22 B-7.73%
2009NZ$11.07 B